Plain-English translation of NCT07582042 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is evaluating a specialized vision measurement technique called fundus-controlled perimetry in patients with geographic atrophy—a serious eye condition that causes vision loss in older adults—who are already being treated with pegcetacoplan injections. The study aims to see whether this new measurement approach can better track how the disease progresses and how well the medication is working.
Doctors currently have limited ways to precisely measure vision changes in geographic atrophy. This trial is testing whether a newer, more personalized vision testing method can provide better information about disease progression and treatment response.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic six times over the study period. At each visit, you'll have your vision tested, receive specialized vision field testing tailored to your specific eye condition, and undergo various eye imaging scans (some optional). Some visits will also include a questionnaire about how your vision affects your daily activities. All visits and tests are designed to monitor how your condition is changing while you continue receiving your regular pegcetacoplan treatment.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States